MCRB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $65,380.82

Seres Therapeutics Insider Trading History Chart

Seres Therapeutics Share Price & Price History

^$0.59

▲ +0.0099 (1.71%)

As of 04/11/2025 05:00 PM ET

Days: 30 | 90 | 365

Seres Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/18/2025	Eric D Shaff	CEO	Sell	12,726	$0.81	$10,308.06	192,039
2/18/2025	Matthew R Henn	Insider	Sell	3,953	$0.81	$3,201.93	84,443
2/18/2025	Thomas Desrosier	EVP	Sell	4,300	$0.81	$3,483.00	142,456
11/18/2024	Eric D Shaff	CEO	Sell	2,505	$0.54	$1,352.70	170,389
11/18/2024	Moltke Lisa Von	Insider	Sell	977	$0.54	$527.58	32,415
11/18/2024	Thomas Desrosier	EVP	Sell	878	$0.54	$474.12	135,192
10/28/2024	Eric D Shaff	CEO	Sell	8,748	$0.69	$6,036.12	165,082
10/28/2024	Moltke Lisa Von	Insider	Sell	4,334	$0.69	$2,990.46	30,423
10/28/2024	Thomas Desrosier	EVP	Sell	4,259	$0.69	$2,938.71	133,414
8/16/2024	Eric D Shaff	CEO	Sell	2,518	$0.84	$2,115.12	145,993
8/16/2024	Moltke Lisa Von	Insider	Sell	973	$0.84	$817.32	21,013
8/16/2024	Thomas Desrosier	EVP	Sell	873	$0.84	$733.32	124,173
8/5/2024	Teresa L Young	Insider	Sell	24,480	$1.08	$26,438.40	78,178
5/15/2024	Eric D Shaff	CEO	Sell	2,435	$0.94	$2,288.90	140,698
5/15/2024	Moltke Lisa Von	Insider	Sell	939	$0.94	$882.66	19,017
5/15/2024	Thomas Desrosier	EVP	Sell	843	$0.94	$792.42	122,390
2/16/2024	David Arkowitz	CFO	Sell	3,939	$1.08	$4,254.12	182,442
2/16/2024	Eric D Shaff	CEO	Sell	11,549	$1.08	$12,472.92	135,321
2/16/2024	Teresa L Young	Insider	Sell	3,374	$1.08	$3,643.92	15,705
10/30/2023	David Arkowitz	CFO	Sell	4,066	$1.35	$5,489.10	175,756
10/30/2023	Eric D Shaff	CEO	Sell	8,552	$1.35	$11,545.20	115,620
10/30/2023	Paula Cloghessy	Insider	Sell	2,904	$1.35	$3,920.40	45,684
10/30/2023	Thomas Desrosier	EVP	Sell	4,156	$1.35	$5,610.60	113,891
4/28/2023	David S Ege	Insider	Sell	7,038	$5.19	$36,527.22	59,696
10/31/2022	David S Ege	Insider	Sell	5,012	$7.93	$39,745.16	46,734
7/5/2022	Health Ltp Fund Ge Nutritional	Major Shareholder	Buy	8,738,243	$3.15	$27,525,465.45	5,875,711

See Full Table

SEC Filings (Institutional Ownership Changes) for Seres Therapeutics (NASDAQ:MCRB)

59.34% of Seres Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Seres Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Millennium Management LLC	1,810,719	$1.51M	0.0%	+77.2%	1.061%
2/17/2025	Cantor Fitzgerald L. P.	95,740	$80K	0.0%	-65.9%	0.056%
2/14/2025	Jane Street Group LLC	58,736	$49K	0.0%	+181.4%	0.034%
2/14/2025	Schonfeld Strategic Advisors LLC	100,700	$84K	0.0%	-76.8%	0.059%
2/14/2025	Northern Trust Corp	262,683	$0.22M	0.0%	+20.4%	0.154%
2/12/2025	Geode Capital Management LLC	1,510,432	$1.26M	0.0%	+8.8%	0.885%
2/11/2025	LPL Financial LLC	94,787	$79K	0.0%	-22.4%	0.056%
2/10/2025	Avantax Advisory Services Inc.	45,179	$38K	0.0%	+170.9%	0.026%
2/6/2025	Charles Schwab Investment Management Inc.	865,825	$0.72M	0.0%	+15.6%	0.507%
1/30/2025	Vontobel Holding Ltd.	938,295	$0.78M	0.0%	+137.6%	0.550%
1/17/2025	Janney Montgomery Scott LLC	48,500	$40K	0.0%	-29.8%	0.028%
11/20/2024	Virtu Financial LLC	58,791	$56K	0.0%	+44.8%	0.034%
11/16/2024	Geode Capital Management LLC	1,388,639	$1.31M	0.0%	+22.5%	0.816%
11/15/2024	State Street Corp	383,248	$0.36M	0.0%	+12.9%	0.225%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	44,972	$43K	0.0%	-64.8%	0.026%
11/14/2024	Providence Wealth Advisors LLC	98,500	$93K	0.1%	+29.2%	0.058%
11/13/2024	FMR LLC	22,857,260	$21.63M	0.0%	+0.6%	13.430%
11/12/2024	Charles Schwab Investment Management Inc.	748,718	$0.71M	0.0%	+42.4%	0.440%
10/16/2024	Vontobel Holding Ltd.	394,826	$0.37M	0.0%	N/A	0.261%
9/16/2024	Point72 DIFC Ltd	87,754	$64K	0.0%	N/A	0.058%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	127,634	$92K	0.0%	N/A	0.084%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	127,634	$92K	0.0%	N/A	0.084%
8/14/2024	Point72 DIFC Ltd	87,754	$64K	0.0%	N/A	0.058%
8/9/2024	Providence Wealth Advisors LLC	76,250	$58K	0.0%	+49.5%	0.050%
8/1/2024	Rhumbline Advisers	55,112	$40K	0.0%	-61.0%	0.036%
5/20/2024	Virtu Financial LLC	94,510	$73K	0.0%	N/A	0.062%
5/15/2024	Price T Rowe Associates Inc. MD	298,111	$0.23M	0.0%	-18.0%	0.197%
5/10/2024	Vanguard Group Inc.	6,734,821	$5.21M	0.0%	+12.1%	4.460%
5/1/2024	BNP Paribas Financial Markets	46,549	$36K	0.0%	-19.8%	0.031%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	50,102	$39K	0.0%	N/A	0.033%
2/14/2024	Pennant Investors LP	292,300	$0.41M	0.1%	N/A	0.226%
2/13/2024	Tower Research Capital LLC TRC	38,091	$53K	0.0%	+668.6%	0.029%
2/1/2024	Handelsbanken Fonder AB	1,100,000	$1.54M	0.0%	+10.0%	0.851%
1/24/2024	Clear Creek Financial Management LLC	26,950	$38K	0.0%	-47.6%	0.021%
1/12/2024	SG Americas Securities LLC	52,080	$73K	0.0%	N/A	0.040%
12/7/2023	Hudson Bay Capital Management LP	1,999,800	$4.76M	0.0%	+127.3%	1.547%
11/22/2023	Graham Capital Management L.P.	206,838	$0.49M	0.0%	+731.3%	0.160%
11/14/2023	Corton Capital Inc.	23,245	$55K	0.0%	-64.7%	0.018%
11/14/2023	Profund Advisors LLC	155,798	$0.37M	0.0%	+11.9%	0.121%
11/13/2023	Federated Hermes Inc.	8,981,717	$21.38M	0.1%	-21.2%	6.949%
11/13/2023	Dark Forest Capital Management LP	117,498	$0.28M	0.0%	N/A	0.091%
11/13/2023	Aigen Investment Management LP	75,241	$0.18M	0.0%	+577.1%	0.058%
11/13/2023	FMR LLC	19,230,692	$45.77M	0.0%	+0.2%	14.878%
11/13/2023	Rafferty Asset Management LLC	936,382	$2.23M	0.0%	+21.1%	0.724%
11/7/2023	Quantbot Technologies LP	50,400	$0.12M	0.0%	N/A	0.039%
11/7/2023	Barclays PLC	461,209	$1.10M	0.0%	+24.3%	0.360%
10/30/2023	Arete Wealth Advisors LLC	24,900	$59K	0.0%	+99.2%	0.019%
10/23/2023	Commonwealth Equity Services LLC	11,040	$26K	0.0%	N/A	0.009%
10/19/2023	Simplicity Solutions LLC	11,294	$27K	0.0%	N/A	0.009%
10/11/2023	Vontobel Holding Ltd.	17,000	$40K	0.0%	-52.6%	0.013%
8/14/2023	Great Point Partners LLC	938,067	$4.49M	0.9%	N/A	0.732%
8/14/2023	UniSuper Management Pty Ltd	415,292	$1.99M	0.0%	N/A	0.324%
8/14/2023	Parallax Volatility Advisers L.P.	134,901	$0.65M	0.0%	N/A	0.105%
8/14/2023	Graham Capital Management L.P.	24,881	$0.12M	0.0%	N/A	0.019%
8/11/2023	Natixis	99,000	$0.47M	0.0%	N/A	0.077%
8/11/2023	E Fund Management Co. Ltd.	41,581	$0.20M	0.0%	+206.1%	0.032%
8/11/2023	ExodusPoint Capital Management LP	594,895	$2.85M	0.0%	N/A	0.464%
8/10/2023	Profund Advisors LLC	139,249	$0.67M	0.0%	+210.4%	0.109%
8/9/2023	BNP Paribas Arbitrage SNC	154,663	$0.74M	0.0%	+61.9%	0.121%
8/7/2023	Principal Financial Group Inc.	45,205	$0.22M	0.0%	+21.5%	0.035%
8/4/2023	American International Group Inc.	46,820	$0.22M	0.0%	+37.7%	0.037%
8/3/2023	Jennison Associates LLC	1,392,356	$6.67M	0.0%	+109.5%	1.089%
8/2/2023	Handelsbanken Fonder AB	1,000,000	$4.79M	0.0%	+25.0%	0.782%
7/31/2023	LPL Financial LLC	115,058	$0.55M	0.0%	+20.3%	0.090%
7/31/2023	Alpha DNA Investment Management LLC	138,536	$0.66M	0.2%	N/A	0.108%
7/28/2023	Mach 1 Financial Group LLC	94,961	$0.46M	0.1%	N/A	0.074%
7/26/2023	Janney Montgomery Scott LLC	90,285	$0.43M	0.0%	-11.7%	0.071%
7/25/2023	Raymond James & Associates	10,052	$48K	0.0%	N/A	0.008%
7/24/2023	Vontobel Holding Ltd.	35,865	$0.17M	0.0%	+74.6%	0.028%
7/21/2023	Creative Planning	17,304	$83K	0.0%	N/A	0.014%
7/19/2023	Teacher Retirement System of Texas	27,360	$0.13M	0.0%	-10.9%	0.021%
7/18/2023	Diversified Trust Co	10,000	$48K	0.0%	N/A	0.008%
7/17/2023	Clear Creek Financial Management LLC	54,200	$0.26M	0.0%	N/A	0.042%
7/14/2023	Aries Wealth Management	18,000	$86K	0.0%	+50.0%	0.014%
7/13/2023	Cambridge Investment Research Advisors Inc.	44,844	$0.22M	0.0%	N/A	0.035%
7/10/2023	AE Wealth Management LLC	95,188	$0.46M	0.0%	N/A	0.074%
7/7/2023	Auour Investments LLC	17,000	$81K	0.0%	N/A	0.013%
5/16/2023	Avoro Capital Advisors LLC	1,295,000	$7.34M	0.1%	N/A	1.013%
5/15/2023	Atom Investors LP	90,388	$0.51M	0.3%	-5.4%	0.071%
5/12/2023	Profund Advisors LLC	44,859	$0.25M	0.0%	N/A	0.035%
5/11/2023	PFG Investments LLC	20,500	$0.12M	0.0%	N/A	0.016%
5/11/2023	FMR LLC	18,911,458	$107.23M	0.0%	+1.2%	14.794%
5/11/2023	Knott David M Jr	315,000	$1.79M	0.7%	+57.4%	0.246%
5/11/2023	E Fund Management Co. Ltd.	13,585	$77K	0.0%	-18.5%	0.011%
5/10/2023	Oppenheimer & Co. Inc.	37,111	$0.21M	0.0%	N/A	0.029%
5/10/2023	Simplify Asset Management Inc.	550,626	$3.12M	0.4%	N/A	0.431%
5/8/2023	Federated Hermes Inc.	15,277,356	$86.62M	0.2%	-15.5%	11.951%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	24,010	$0.14M	0.0%	+39.0%	0.019%
5/4/2023	Barclays PLC	110,060	$0.62M	0.0%	-37.7%	0.086%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	62,240	$0.35M	0.0%	+16.9%	0.049%
5/2/2023	Venturi Wealth Management LLC	20,000	$0.11M	0.0%	N/A	0.016%
4/28/2023	SG Americas Securities LLC	43,684	$0.25M	0.0%	+206.6%	0.034%
4/28/2023	Janney Montgomery Scott LLC	102,281	$0.58M	0.0%	+5.5%	0.080%
4/28/2023	Handelsbanken Fonder AB	800,000	$4.54M	0.0%	N/A	0.626%
4/26/2023	Jennison Associates LLC	664,734	$3.77M	0.0%	-0.6%	0.527%
4/20/2023	Hennion & Walsh Asset Management Inc.	61,090	$0.35M	0.0%	-3.3%	0.048%
4/18/2023	Macroview Investment Management LLC	5,750	$33K	0.1%	N/A	0.005%
4/12/2023	Vontobel Holding Ltd.	20,539	$0.12M	0.0%	N/A	0.016%
4/11/2023	Aries Wealth Management	12,000	$68K	0.0%	+20.0%	0.010%
3/23/2023	MetLife Investment Management LLC	31,931	$0.18M	0.0%	-17.2%	0.025%

Data available starting January 2016

See Full Table

Seres Therapeutics, Inc., a microbiome therapeutics company, develop microbiome therapeutics to treat the modulation of the colonic microbiome. It develops a novel class of biological drugs that are designed to treat by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. The company's lead product candidate is VOWST, an oral microbiome therapeutic that has completed Phase III clinical trial for the treatment of recurrent Clostridioides difficile infection. Its product pipeline also includes SER-155, an investigational oral fermented microbiome therapeutic which is in Phase 1b clinical trials for the treatment of gastrointestinal infections, bacteremia, and graft versus host disease in immunocompromised patients including patients receiving allogeneic hematopoietic stem cell transplantation. In addition, the company engages in the development of SER-287 which is in Phase 2b and SER-301 that is in Phase 1b to treat ulcerative colitis. Further, it has license Agreement with NHSc Rx License GmbH for the therapeutic products based on the microbiome technology, which includes VOWST product candidate, which is developed for the treatment of CDI and recurrent CDI; and collaboration license agreement with Société des Produits Nestlé S.A. (Nestlé) for the development and commercialization of certain product candidates for the treatment and management of CDI and inflammatory bowel disease including UC and Crohn's disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $0.59

$0.57

$0.61

50 Day Range

MA: $0.72

$0.52

$0.84

52 Week Range

Now: $0.59

$0.46

$1.53

Volume

810,367 shs

Average Volume

3,249,733 shs

Market Capitalization

$102.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.54

Who are the company insiders with the largest holdings of Seres Therapeutics?: Seres Therapeutics' top insider shareholders include:
Eric D Shaff (CEO)
David Arkowitz (CFO)
Thomas Desrosier (EVP)
Matthew R Henn (Insider)
Teresa L Young (Insider)
David S Ege (Insider)
Paula Cloghessy (Insider)
Moltke Lisa Von (Insider)
Learn More about top insider investors at Seres Therapeutics.